Select therapeutic use:
Indications for LEVSIN/SL:
Adjunct in peptic ulcer. Irritable bowel syndrome. Infant colic.
1–2 tabs sublingually, swallowed, or chewed every 4 hrs or as needed; max 12 tabs/day.
<2yrs: not recommended. ≥2yrs: ½ –1 tab sublingually, swallowed, or chewed every 4 hrs or as needed; max 6 tabs/day.
Glaucoma. Unstable cardiovascular status in acute hemorrhage. GI or urinary tract obstruction. Paralytic ileus, intestinal atony of elderly or debilitated patients. Toxic megacolon. Severe ulcerative colitis. Myasthenia gravis.
High environmental temperature. Diarrhea. Autonomic neuropathy. Impaired cardiac or renal function. Cardiovascular disease. Hypertension. Hyperthyroidism. Hiatal hernia with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers.
Antacids may inhibit absorption. Additive anticholinergic effects with other anticholinergics, amantadine, type I antiarrhythmics, antihistamines, phenothiazines, tricyclics, MAOIs.
Anticholinergic effects, drowsiness.
Formerly known under the brand name Levsin Drops.
Tabs, SL—100, 500; Drops—contact supplier